These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9250853)

  • 1. Use of antimicrobial agents and drug resistance.
    Swartz MN
    N Engl J Med; 1997 Aug; 337(7):491-2. PubMed ID: 9250853
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.
    Seppälä H; Klaukka T; Vuopio-Varkila J; Muotiala A; Helenius H; Lager K; Huovinen P
    N Engl J Med; 1997 Aug; 337(7):441-6. PubMed ID: 9250845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Resistance to macrolides in Streptococcus pyogenes].
    Bellido JL; García-Sáenz JA; Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
    Rev Esp Quimioter; 1998 Sep; 11(3):196-204. PubMed ID: 9795305
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan.
    Hsueh PR; Shyr JM; Wu JJ
    Clin Infect Dis; 2005 Mar; 40(6):903-5. PubMed ID: 15736030
    [No Abstract]   [Full Text] [Related]  

  • 5. Lowering the rate of antibiotic resistance.
    Rohner CD; Force RW
    J Fam Pract; 1997 Nov; 45(5):374. PubMed ID: 9374954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
    Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resistance to erythromycin in strains of Streptococcus pyogenes isolated in the province of Barcelona].
    Viñado B; Domínguez J; Rodrigo C; Matas L
    Med Clin (Barc); 1999 Apr; 112(14):556. PubMed ID: 10363246
    [No Abstract]   [Full Text] [Related]  

  • 8. [Resistance to penicillin and erythromycin of Streptococcus pneumoniae and Streptococcus pyogenes isolated from community-acquired respiratory infections in Spain between 1986-1999 and its relationship with the use of beta-lactams and macrolides].
    Granizo Martínez JJ
    Rev Esp Quimioter; 2005 Mar; 18(1):83-5. PubMed ID: 15915241
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis of bacterial resistance to macrolides.
    Halpern MT; Schmier JK; Snyder LM; Asche C; Sarocco PW; Lavin B; Nieman R; Mandell LA
    J Antimicrob Chemother; 2005 May; 55(5):748-57. PubMed ID: 15772147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin resistance in Finland declines after reduction in macrolide use.
    Am J Health Syst Pharm; 1997 Nov; 54(21):2436-7. PubMed ID: 9359947
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan.
    Hsueh PR; Shyr JM; Wu JJ
    Clin Microbiol Infect; 2006 Mar; 12(3):296-8. PubMed ID: 16451421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptococcus pyogenes erythromycin resistance in Italy.
    Bassetti M; Mantero E; Gatti G; Di Biagio A; Bassetti D
    Emerg Infect Dis; 1999; 5(2):302-3. PubMed ID: 10221991
    [No Abstract]   [Full Text] [Related]  

  • 13. Community-acquired antimicrobial resistance: is it controllable?
    Liñares J
    Int J Clin Pract Suppl; 1998 Jun; 95():23-6. PubMed ID: 9796552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide-resistant group a streptococcus--now in the United States.
    Huovinen P
    N Engl J Med; 2002 Apr; 346(16):1243-5. PubMed ID: 11961156
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythromycin-resistant Streptococcus pyogenes in Argentina.
    Lopardo HA; Hernandez C; Vidal P; Vazquez M; Rosaenz L; Rubinstein G; Smayevsky J; Tokumoto M; Fernandez Lausi A; Daher O; Kaufman S; Soriano SV; Brasili S; Bottiglieri M; Carranza MC
    Medicina (B Aires); 2004; 64(2):143-5. PubMed ID: 15628302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W; Raz R; Colodner R; Keness Y
    Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.
    Bergman M; Huikko S; Pihlajamäki M; Laippala P; Palva E; Huovinen P; Seppälä H;
    Clin Infect Dis; 2004 May; 38(9):1251-6. PubMed ID: 15127336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of erythromycin resistance genes from strains of Streptococcus pyogenes that have developed resistance to levofloxacin.
    Billal DS; Hotomi M; Yan SS; Fedorko DP; Shimada J; Fujihara K; Yamanaka N
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):225-8. PubMed ID: 19345038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
    Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
    Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.